Literature DB >> 8005010

Malignancy-induced secondary achalasia.

H P Parkman1, S Cohen.   

Abstract

Secondary achalasia refers to the development of clinical, radiographic, and manometric findings of achalasia as a result of (i.e., secondary to) another underlying disorder. A variety of malignancies have been associated with secondary achalasia. Adenocarcinoma of the esophagogastric junction accounts for the majority of cases of malignancy-induced achalasia, however, noncontiguous tumors may also cause this disorder. Although rare, malignancy-induced achalasia will occasionally be encountered by gastroenterologists and gastrointestinal radiologists who see patients with dysphagia and/or achalasia. Since treatment is aimed at the underlying neoplasm, it is important to recognize this disorder. Three clinical features suggest the possibility of malignancy as a cause of achalasia: 1) short duration of dysphagia (< 1 year); 2) significant weight loss (> 15 pounds); and 3) age > 55 years. The presence of any of these should at least raise a suspicion of malignancy. Diagnosis may not be evident on routine esophagrams and endoscopy, and requires clinical suspicion for further evaluation with thoraco-abdominal CT scanning and endoscopic ultrasonography.

Entities:  

Mesh:

Year:  1994        PMID: 8005010

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  3 in total

1.  Uncommon cause of dysphagia: paraneoplastic achalasia.

Authors:  Mukesh Nasa; Shashank Bhansali; Narendra Singh Choudhary; Randhir Sud
Journal:  BMJ Case Rep       Date:  2018-03-07

2.  Pseudoachalasia of the cardia secondary to nongastrointestinal neoplasia.

Authors:  Jose Luis Ulla; Estela Fernandez-Salgado; Victoria Alvarez; Alberto Ibañez; Santiago Soto; Daniel Carpio; Javier Vazquez-Sanluis; Luis Ledo; Enrique Vazquez-Astray
Journal:  Dysphagia       Date:  2007-08-15       Impact factor: 3.438

3.  Primary squamous cell carcinoma of the liver initially presenting with pseudoachalasia.

Authors:  Mun Ki Choi; Gwang Ha Kim; Geun Am Song; Hyung Seok Nam; Yang Seon Yi; Kang Hee Ahn; Suk Kim; Joo Yeun Kim; Do Youn Park
Journal:  Gut Liver       Date:  2012-04-17       Impact factor: 4.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.